New Studies
Major findings from Lancet, BMJ, NEJM, JAMA, and other leading journals
First In Vivo CRISPR Gene Editing Treatment Shows Promise for Rare Blood Disorder
First clinical trial of in vivo CRISPR gene editing for hereditary angioedema shows promising results. The investigational therapy targets genetic…
Editor's Top Picks
Minocycline Stroke Trial Debate Highlights Neuroprotection Research Challenges
Scientific debate in The Lancet highlights persistent challenges in stroke neuroprotection research following criticism of the EMPHASIS minocycline trial. Researchers…
Submit Your Paper →
More form New Studies
Multi-Cancer Screening Test Fails Primary Endpoint but Reveals Promising Early Detection Signals
World's largest multi-cancer detection trial fails primary mortality endpoint but reveals important early detection capabilities.…
Longevity Science Takes Center Stage at Bay Area Festival as Industry Seeks Mainstream Appeal
The longevity science industry is using festival formats to engage mainstream audiences and build acceptance…
Argentine Biochemist Daniela Hozbor Advances Global Pertussis Vaccine Research
Argentine biochemist Dr. Daniela Hozbor combines molecular research with vaccine development to address global pertussis…
Biotech Industry Faces Strategic Inflection Point Amid Cost Pressures and Innovation Demands
Veteran biotech executive Jeremy Levin discusses how the industry faces a critical juncture with $2.6…
Gut microbiome screening could predict Parkinson’s disease risk years before symptoms emerge
New research published in Nature Medicine reveals that gut microbiome analysis could identify Parkinson's disease…